IgG / California Pacific Medical Center / Macmillan Publishers Limited / /
Country
United States / /
Currency
pence / / /
Event
Product Issues / FDA Phase / /
Facility
California Pacific Medical Center Research Institute / Stanford University / Campus Drive / /
IndustryTerm
live cell imaging / start site / chemical uncoupler / live model systems / energy / breast cancer model systems / transcriptional start site / gene product / confocal imaging / energy dissipation / time-lapse imaging / live confocal imaging / /
MedicalCondition
thereby promoting tumor / high histological-grade tumors / novel breast cancer / primary breast cancer / low and intermediate-grade primary breast cancer A Sayeed1 / thereby augmenting tumor / UCP2-KD tumor / poorly differentiated tumor / intermediate-grade primary breast cancer / clinical disease / poorly differentiated breast cancer / metastatic breast cancer / responsive tumor cells / breast tumor / such tumors / high-grade breast cancer / primary breast tumor / Methods Primary breast carcinoma / human breast cancer / breast cancer / primary tumors / poorly differentiated tumors / tumor / mitochondrial dysfunction / Although cancer / cancer / UCP2-transduced tumor / UCP2-negative tumors / tumors / Disease / thereby enhancing tumor / Negative tumors / siRNA-transfected tumor / formalin-fixed primary breast cancer / solid tumor / high-grade tumor / particularly promising tumor / full-sized tumor / UCP2 overexpressing tumor / negaitive tumors / aggressive tumor / breast tumors / tumor cells / TGFb-resistant high-grade tumors / cases Positive tumors / moderately differentiated breast tumors / improved disease / intermediate-grade tumors / live tumor / primary tumor / /
Organization
Department of Chemical and Systems Biology / Stanford University / California Pacific Medical Center Research Institute / /
Citation: Cell Death and Disease[removed], e53; doi:[removed]cddis[removed] & 2010 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis Negative regulation of UCP2 by TGFb signaling